Annual FCF
-$20.55 M
+$108.60 M+84.09%
31 December 2023
Summary:
Wave Life Sciences annual free cash flow is currently -$20.55 million, with the most recent change of +$108.60 million (+84.09%) on 31 December 2023. During the last 3 years, it has risen by +$96.77 million (+82.49%). WVE annual FCF is now -471.04% below its all-time high of -$3.60 million, reached on 31 December 2013.WVE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$46.86 M
-$19.34 M-70.28%
30 September 2024
Summary:
Wave Life Sciences quarterly free cash flow is currently -$46.86 million, with the most recent change of -$19.34 million (-70.28%) on 30 September 2024. Over the past year, it has dropped by -$12.21 million (-35.22%). WVE quarterly FCF is now -155.11% below its all-time high of $85.03 million, reached on 31 March 2023.WVE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$141.82 M
-$12.21 M-9.42%
30 September 2024
Summary:
Wave Life Sciences TTM free cash flow is currently -$141.82 million, with the most recent change of -$12.21 million (-9.42%) on 30 September 2024. Over the past year, it has dropped by -$121.23 million (-588.64%). WVE TTM FCF is now -8569.01% below its all-time high of -$1.64 million, reached on 31 March 2015.WVE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WVE Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +84.1% | -35.2% | -588.6% |
| 3 y3 years | +82.5% | -65.7% | -23.9% |
| 5 y5 years | +37.4% | -6.2% | +14.5% |
WVE Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +84.1% | -155.1% | at low | -3421.0% | at low |
| 5 y | 5 years | at high | +89.3% | -155.1% | +25.1% | -3421.0% | +26.2% |
| alltime | all time | -471.0% | +89.3% | -155.1% | +25.1% | -8569.0% | +26.2% |
Wave Life Sciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$46.86 M(+70.3%) | -$141.82 M(+9.4%) |
| June 2024 | - | -$27.52 M(-18.7%) | -$129.62 M(-7.0%) |
| Mar 2024 | - | -$33.85 M(+0.8%) | -$139.43 M(+578.6%) |
| Dec 2023 | -$20.55 M(-84.1%) | -$33.59 M(-3.1%) | -$20.55 M(-0.2%) |
| Sept 2023 | - | -$34.66 M(-7.2%) | -$20.59 M(+71.0%) |
| June 2023 | - | -$37.33 M(-143.9%) | -$12.04 M(+199.0%) |
| Mar 2023 | - | $85.03 M(-352.7%) | -$4.03 M(-96.9%) |
| Dec 2022 | -$129.14 M(+44.2%) | -$33.64 M(+28.9%) | -$129.14 M(+25.9%) |
| Sept 2022 | - | -$26.10 M(-11.0%) | -$102.55 M(-2.1%) |
| June 2022 | - | -$29.31 M(-26.9%) | -$104.72 M(+23.0%) |
| Mar 2022 | - | -$40.08 M(+468.7%) | -$85.15 M(-4.9%) |
| Dec 2021 | -$89.55 M(-23.7%) | -$7.05 M(-75.1%) | -$89.55 M(-21.8%) |
| Sept 2021 | - | -$28.28 M(+190.4%) | -$114.48 M(+7.6%) |
| June 2021 | - | -$9.74 M(-78.1%) | -$106.43 M(-21.1%) |
| Mar 2021 | - | -$44.48 M(+39.1%) | -$134.97 M(+15.0%) |
| Dec 2020 | -$117.32 M(-38.9%) | -$31.97 M(+58.0%) | -$117.32 M(-20.7%) |
| Sept 2020 | - | -$20.24 M(-47.1%) | -$147.93 M(-13.9%) |
| June 2020 | - | -$38.28 M(+42.7%) | -$171.84 M(+2.2%) |
| Mar 2020 | - | -$26.83 M(-57.1%) | -$168.09 M(-12.5%) |
| Dec 2019 | -$192.15 M | -$62.59 M(+41.8%) | -$192.15 M(+15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$44.15 M(+27.9%) | -$165.85 M(+7.6%) |
| June 2019 | - | -$34.53 M(-32.2%) | -$154.10 M(+207.6%) |
| Mar 2019 | - | -$50.89 M(+40.3%) | -$50.10 M(+52.7%) |
| Dec 2018 | -$32.80 M(-68.0%) | -$36.28 M(+12.0%) | -$32.80 M(+40.5%) |
| Sept 2018 | - | -$32.40 M(-146.6%) | -$23.35 M(+16.9%) |
| June 2018 | - | $69.47 M(-306.8%) | -$19.97 M(-82.7%) |
| Mar 2018 | - | -$33.59 M(+25.2%) | -$115.09 M(+12.2%) |
| Dec 2017 | -$102.56 M(+173.5%) | -$26.83 M(-7.5%) | -$102.56 M(+11.7%) |
| Sept 2017 | - | -$29.02 M(+13.1%) | -$91.80 M(+21.0%) |
| June 2017 | - | -$25.66 M(+21.9%) | -$75.89 M(+49.6%) |
| Mar 2017 | - | -$21.05 M(+31.0%) | -$50.72 M(+35.3%) |
| Dec 2016 | -$37.49 M(+160.7%) | -$16.08 M(+22.7%) | -$37.49 M(+29.0%) |
| Sept 2016 | - | -$13.11 M(+2585.9%) | -$29.05 M(+50.5%) |
| June 2016 | - | -$488.00 K(-93.8%) | -$19.30 M(-6.2%) |
| Mar 2016 | - | -$7.82 M(+2.4%) | -$20.57 M(+43.0%) |
| Dec 2015 | -$14.38 M(+186.8%) | -$7.64 M(+127.5%) | -$14.38 M(+113.2%) |
| Sept 2015 | - | -$3.36 M(+91.5%) | -$6.75 M(+99.1%) |
| June 2015 | - | -$1.75 M(+7.2%) | -$3.39 M(+107.2%) |
| Mar 2015 | - | -$1.64 M | -$1.64 M |
| Dec 2014 | -$5.02 M(+39.4%) | - | - |
| Dec 2013 | -$3.60 M | - | - |
FAQ
- What is Wave Life Sciences annual free cash flow?
- What is the all time high annual FCF for Wave Life Sciences?
- What is Wave Life Sciences annual FCF year-on-year change?
- What is Wave Life Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for Wave Life Sciences?
- What is Wave Life Sciences quarterly FCF year-on-year change?
- What is Wave Life Sciences TTM free cash flow?
- What is the all time high TTM FCF for Wave Life Sciences?
- What is Wave Life Sciences TTM FCF year-on-year change?
What is Wave Life Sciences annual free cash flow?
The current annual FCF of WVE is -$20.55 M
What is the all time high annual FCF for Wave Life Sciences?
Wave Life Sciences all-time high annual free cash flow is -$3.60 M
What is Wave Life Sciences annual FCF year-on-year change?
Over the past year, WVE annual free cash flow has changed by +$108.60 M (+84.09%)
What is Wave Life Sciences quarterly free cash flow?
The current quarterly FCF of WVE is -$46.86 M
What is the all time high quarterly FCF for Wave Life Sciences?
Wave Life Sciences all-time high quarterly free cash flow is $85.03 M
What is Wave Life Sciences quarterly FCF year-on-year change?
Over the past year, WVE quarterly free cash flow has changed by -$12.21 M (-35.22%)
What is Wave Life Sciences TTM free cash flow?
The current TTM FCF of WVE is -$141.82 M
What is the all time high TTM FCF for Wave Life Sciences?
Wave Life Sciences all-time high TTM free cash flow is -$1.64 M
What is Wave Life Sciences TTM FCF year-on-year change?
Over the past year, WVE TTM free cash flow has changed by -$121.23 M (-588.64%)